Segix Farma

Segix Farma, operating primarily as Segix Italia, is an Italian pharmaceutical company specializing in the development and commercialization of specialty medicines and primary care products. The company maintains a robust presence in the Italian healthcare market, with a particular focus on therapeutic areas such as gynecology, pediatrics, and respiratory health. In 2019, Segix was acquired by Neopharmed Gentili, a leading Italian pharmaceutical group, to consolidate its position in the domestic market and expand its portfolio of established brands. Key products in the Segix portfolio include Prontogest for hormonal support and Fertifol for prenatal care. The company continues to provide essential therapeutic solutions through its integrated distribution network and expertise in the Italian regulatory landscape.